company and its subsidiaries has revised its strategies to cope with the situation by focusing its marketing towards industries least impacted by the coronavirus, such as the food and pharmaceutical
consideration 3. Approved the appropriate price range of the value of assets disposal according to opinion of an Independent Financial Advisor in a total of 1,636.50 - 1,684.50 million baht and set criteria for
consideration 3. Approved the appropriate price range of the value of assets disposal according to opinion of an Independent Financial Advisor in a total of 1,636.50 - 1,684.50 million baht and set criteria for
financial instruments in 3Q2018 were Baht 464 million, an increase of 45% from 3Q2017, due to an improved performance of the Company’s wide range of investments. 2.Expenses 2.1 Employee benefits expenses The
consideration of market specificities and nuanced approaches for different engagements • Numerous engagement options and reference points for investors, supported by wide range of tools, benchmark assessments and
segments while leverage synergies from acquisition. With CSL combined, in 2018, service revenue (excluding IC), is expected to grow in a range of 7-8%, 2% of which is from full consolidation of CSL. Through
. UTILITY PUBLIC COMPANY LIMITED JSP: JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED JTS: JASMINE TECHNOLOGY SOLUTION PUBLIC COMPANY LIMITED JUBILE: JUBILEE ENTERPRISE PUBLIC COMPANY
distributed to Shareholders. As the outbreak of the Coronavirus Disease 2019 (“COVID-19”) in Thailand which is rapidly spread and could cover wider range. In this regard, the government has announced a state of
.? [The average scores range from 5 (the lowest) to 1 (the highest)]. Major issues found among the inspected audit firms included non-compliance with auditing standards and inefficient work monitoring
addition, trigger fund fees are higher than those of general funds and the total expense ratio (TER) is in the range of 1.12 ? 4.5 percent or a 2.8 percent average compared to 1.8 percent in general equity